Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 3899-3910

  Biton, Jérôme ^a   Semerano, Luca ^a,b   Delavallée, Laure ^a   Lemeiter, Delphine ^a   Laborie, Marion ^c   Grouard Vogel, Géraldine ^c   Boissier, Marie Christophe ^a,b   Bessis, Natacha ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b AVICENNE HOSPITAL   (France)

^c Neovacs SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INFLIXIMAB; L SELECTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA KINOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; IMMUNOTHERAPY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELL COMMUNICATION; DISEASE MODELS, ANIMAL; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY, ACTIVE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953656530     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003372     Document Type: Article

References (37)

1. Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, and G. Kollias. 1991. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J. 10: 4025-4031. (Pubitemid 21905432)
2. Bloquel, C., N. Bessis, M. C. Boissier, D. Scherman, and P. Bigey. 2004. Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-a soluble receptor I variants. Hum. Gene Ther. 15: 189-201. (Pubitemid 38210533)
3. Anderson, P. J. 2005. Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles. Semin. Arthritis Rheum. 34(5, Suppl. 1): 19-22.
4. Le Buanec, H., L. Delavallée, N. Bessis, S. Paturance, B. Bizzini, R. Gallo, D. Zagury, and M. C. Boissier. 2006. TNFa kinoid vaccination-induced neutralizing antibodies to TNFa protect mice from autologous TNFa-driven chronic and acute inflammation. Proc. Natl. Acad. Sci. USA 103: 19442-19447. (Pubitemid 46026050)
5. Delavallée, L., H. Le Buanec, N. Bessis, E. Assier, A. Denys, B. Bizzini, D. Zagury, and M. C. Boissier. 2008. Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFa) transgenic mice vaccinated against TNFa. Ann. Rheum. Dis. 67: 1332-1338.
6. Delavallée, L., L. Semerano, E. Assier, G. Vogel, G. Vuagniaux, M. Laborie, D. Zagury, N. Bessis, and M. C. Boissier. 2009. Active immunization to tumor necrosis factor-a is effective in treating chronic established inflammatory disease: A long-term study in a transgenic model of arthritis. Arthritis Res. Ther. 11: R195.
7. Sakaguchi, S. 2000. Regulatory T cells: Key controllers of immunologic selftolerance. Cell 101: 455-458.
8. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562. (Pubitemid 38680433)
9. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73. (Pubitemid 32044521)
10. Wildin, R. S., S. Smyk-Pearson, and A. H. Filipovich. 2002. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39: 537-545. (Pubitemid 34864555)
11. + regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32. (Pubitemid 33070205)
12. Xystrakis, E., S. E. Boswell, and C. M. Hawrylowicz. 2006. T regulatory cells and the control of allergic disease. Expert Opin. Biol. Ther. 6: 121-133. (Pubitemid 43259893)
13. Coombes, J. L., and K. J. Maloy. 2007. Control of intestinal homeostasis by regulatory T cells and dendritic cells. Semin. Immunol. 19: 116-126. (Pubitemid 46810287)
14. Ehrenstein, M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg, and C. Mauri. 2004. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFa therapy. J. Exp. Med. 200: 277-285. (Pubitemid 39031247)
15. Boissier, M. C., E. Assier, J. Biton, A. Denys, G. Falgarone, and N. Bessis. 2009. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 76: 10-14.
16. Morgan, M. E., R. P. Sutmuller, H. J. Witteveen, L. M. van Duivenvoorde, E. Zanelli, C. J. Melief, A. Snijders, R. Offringa, R. R. de Vries, and R. E. Toes. 2003. CD25+ cell depletion hastens the onset of severe disease in collageninduced arthritis. Arthritis Rheum. 48: 1452-1460. (Pubitemid 36554546)
17. Nguyen, L. T., J. Jacobs, D. Mathis, and C. Benoist. 2007. Where FoxP3- dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56: 509-520.
18. Nadkarni, S., C. Mauri, and M. R. Ehrenstein. 2007. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med. 204: 33-39. (Pubitemid 46148753)
19. +CD25hi Tregulatory cells. Blood 108: 253-261. (Pubitemid 43990636)
20. +CD25+ T regulatory cells. J. Immunol. 179: 154-161. (Pubitemid 46986529)
21. +FOXP3+ regulatory T cells in human peripheral blood. Eur. J. Immunol. 40: 1099-1106.
22. Hayward, M. D., B. K. Jones, A. Saparov, H. S. Hain, A. C. Trillat, M. M. Bunzel, A. Corona, B. Li-Wang, B. Strenkowski, C. Giordano, et al. 2007. An extensive phenotypic characterization of the hTNFa transgenic mice. BMC Physiol. 7: 13.
23. Thwin, M. M., E. Douni, V. Aidinis, G. Kollias, K. Kodama, K. Sato, R. L. Satish, R. Mahendran, and P. Gopalakrishnakone. 2004. Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: A time-course ultrastructural study. Arthritis Res. Ther. 6: R282-R294.
24. Clavel, G., C. Valvason, K. Yamaoka, D. Lemeiter, L. Laroche, M. C. Boissier, and N. Bessis. 2006. Relationship between angiogenesis and inflammation in experimental arthritis. Eur. Cytokine Netw. 17: 202-210.
25. Boissier, M. C., E. Assier, G. Falgarone, and N. Bessis. 2008. Shifting the imbalance from Th1/Th2 to Th17/Treg: The changing rheumatoid arthritis paradigm. Joint Bone Spine 75: 373-375.
26. +CD25+ T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99: 12287-12292.
27. + T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33: 215-223. (Pubitemid 36157659)
28. + CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 140: 360-367. (Pubitemid 40559165)
29. +CD25+ regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50: 2775-2785. (Pubitemid 39209514)
30. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6: R335-R346.
31. +CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 45: 1210-1217. (Pubitemid 44548851)
32. + CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J. Immunol. 180: 2747-2751.
33. Notley, C. A., J. J. Inglis, S. Alzabin, F. E. McCann, K. E. McNamee, and R. O. Williams. 2008. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J. Exp. Med. 205: 2491-2497.
34. + CD25+ Foxp3+ regulatory T cells that express CD103. J. Immunol. 181: 5204-5208.
35. +CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169: 2461-2465. (Pubitemid 34920990)
36. +CD25+ regulatory T cells abrogates their function in vivo. J. Immunol. 177: 4376-4383. (Pubitemid 44469766)
37. Flores-Borja, F., E. C. Jury, C. Mauri, and M. R. Ehrenstein. 2008. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 105: 19396-19401.